Cyclic dinucleotide metal compound, and preparation and application thereof
US-2024317792-A1 · Sep 26, 2024 · US
US9896532B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9896532-B2 |
| Application number | US-201314398427-A |
| Country | US |
| Kind code | B2 |
| Filing date | May 1, 2013 |
| Priority date | May 1, 2012 |
| Publication date | Feb 20, 2018 |
| Grant date | Feb 20, 2018 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
The invention herein disclosed provides for compositions, methods for synthesizing said compositions, and methods for using said compositions, wherein the compositions and methods may be used to bind to and/or deactivate a poison oak oil, such as urushiol. The compositions and methods can be used to treat and/or reduce an inflammatory reaction and/or hypersensitivity to natural compounds found in poison oak, poison ivy, poison sumac, mango, lac tree, cashew nut, and Asian lacquer.
Opening claim text (preview).
I claim: 1. A method for deactivating a catechol in a sample, the method comprising the steps of (i) contacting an oxidant and a catalyst with the sample, wherein the catalyst is a nitroxide, (ii) allowing the oxidant to react with the catechol in the sample thereby creating an orthoquinone; (iii) allowing the orthoquinone to react with the oxidant thereby generating a polymer; the method resulting in deactivating the catechol in the sample. 2. A method for deactivating a catechol in a sample, the method comprising the steps of (i) contacting an oxidant and a catalyst with the sample, wherein the catalyst is a nitroxide precursor, (ii) allowing the oxidant to react with the catechol in the sample thereby creating an orthoquinone; (iii) allowing the orthoquinone to react with the oxidant thereby generating a polymer; the method resulting in deactivating the catechol in the sample. 3. The method of claim 1 , wherein the nitroxide is selected from the group consisting of alkyl nitroxide, Fremy's salt, and acyl nitroxide. 4. The method of claim 1 , wherein the nitroxide is tetramethylpiperidinyloxy (TEMPO). 5. The method of claim 2 , wherein the nitroxide precursor is selected from the group consisting of an amine and a hydroxamic acid. 6. The method of claim 1 , the method further comprising the steps of (iv) providing a free radical initiator, (v) allowing the orthoquinone to react with the free radical initiator, thereby generating a semiquinone radical, (vi) allowing the semiquinone radical to auto-oxidize, or (vii) allowing the semiquinone to polymerize, the method resulting in deactivating the orthoquinone.
Oxidoreductases (1) · CPC title
Skin tests, e.g. intradermal testing, test strips, delayed hypersensitivity · CPC title
Medicinal preparations containing inorganic active ingredients · CPC title
Polymerisation of single ketones · CPC title
of at least one hydroxy group on a six-membered aromatic ring · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.